[Hyperthermic intraperitoneal chemotherapy]
- PMID: 31190081
- DOI: 10.1007/s00104-019-0982-5
[Hyperthermic intraperitoneal chemotherapy]
Abstract
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are recognized as the standard of care for selected patients with peritoneal malignancies. A complete macroscopic cytoreduction is the basis for a successful multimodal treatment. The significance of intraperitoneal chemotherapy is still under discussion. This review explains the principles and the value of HIPEC within the multimodal treatment context.
Keywords: Cytoreductive Surgery; Hyperthermia; Morbidity; Mortality; Perfusion.
Similar articles
-
Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies.Cas Lek Cesk. 2018 Dec 17;157(8):419-428. Cas Lek Cesk. 2018. PMID: 30754979 English.
-
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.World J Surg Oncol. 2016 Feb 24;14(1):42. doi: 10.1186/s12957-016-0804-x. World J Surg Oncol. 2016. PMID: 26912149 Free PMC article.
-
Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.J Surg Oncol. 2015 Jun;111(7):840-7. doi: 10.1002/jso.23889. Epub 2015 Apr 10. J Surg Oncol. 2015. PMID: 25864884
-
[Surgical treatment of peritoneal metastases of gastric cancer].Chirurg. 2018 Sep;89(9):669-677. doi: 10.1007/s00104-018-0625-2. Chirurg. 2018. PMID: 29616280 Review. German.
-
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer].Chirurg. 2021 Jun;92(6):522-527. doi: 10.1007/s00104-021-01371-3. Epub 2021 Feb 23. Chirurg. 2021. PMID: 33620502 Review. German.
Cited by
-
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).Cancers (Basel). 2019 Dec 20;12(1):34. doi: 10.3390/cancers12010034. Cancers (Basel). 2019. PMID: 31877647 Free PMC article. Review.
-
Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites.World J Surg Oncol. 2020 Jul 22;18(1):180. doi: 10.1186/s12957-020-01956-y. World J Surg Oncol. 2020. PMID: 32698824 Free PMC article.
-
Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC).Surg Endosc. 2021 Nov;35(11):6358-6365. doi: 10.1007/s00464-021-08567-y. Epub 2021 Jun 10. Surg Endosc. 2021. PMID: 34114069 Free PMC article.
-
Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy.BMC Pharmacol Toxicol. 2023 Mar 1;24(1):13. doi: 10.1186/s40360-023-00653-2. BMC Pharmacol Toxicol. 2023. PMID: 36859304 Free PMC article.
-
Research progress and treatment status of malignant ascites.Front Oncol. 2024 Dec 16;14:1390426. doi: 10.3389/fonc.2024.1390426. eCollection 2024. Front Oncol. 2024. PMID: 39737405 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical